IMPACT STATEMENT.
The unprecedented pandemic by COVID-19 lead to a special attention to vulnerability of children. Clinical and experimental studies suggest a link between allergy and viral acute RS, whereas any correlation may be established with bacterial acute RS. Anti-allergy treatment may prevent and reduce severity of viral acute RS even though any articles investigated specifically the link between allergy and upper airway involvement by the new coronavirus in children. Nevertheless, in this particular era a regular treatment plan should be adopted in allergic children not only to reduce the risk of viral acute RS but also because symptoms may considerably overlap. Finally, although there is no proof of causation of allergy in chronic RS children, anti-allergy treatment might improve outcomes of its specific treatment.